Mapreg: Toward a novel approach of neuroprotection and treatment of Alzbeimerś disease

Author： Baulieu Etienne-Emile   Robel Paul   Fellous Arlette   Duchossoy Yann   Fontaine-Lenoir Virginie   David Sebastien  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.24, Iss.1, 2004-02, pp. : 63-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parkinson's disease, insulin resistance and novel agents of neuroprotection

By Aviles-Olmos Iciar  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 374-384

Oxford University Press

Access to resources Recommend Favorite

Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases

By Youdim M. B. H.   Fridkin M.   Zheng H.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1455-1471

Springer Publishing Company

Access to resources Recommend Favorite

The BRAINz trial: a novel approach to acetylcholinesterase-inhibitor treatment for Alzheimer’s disease

By Wilkinson David   Roughan Laura  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

Cellular Delivery of Trophic Factors for the Treatment of Huntington's Disease: Is Neuroprotection Possible?

By Kordower J.H.   Isacson O.   Emerich D.F.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 4-20

Elsevier

Access to resources Recommend Favorite

Neuroprotection in neuro-ophthalmic disease

By Levin Leonard A.  

Neuro-Ophthalmology, Vol. 24, Iss. 3, 2000-10 ,pp. : 383-386

Informa Healthcare

Access to resources Recommend Favorite